Li Fengjin, He Xiaoli, Niu Wenying, Feng Yuenan, Bian Jingqi, Kuang Haixue, Xiao Hongbin
Department of Basic Medicine, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China; Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.
Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.
Regul Toxicol Pharmacol. 2016 Aug;79:1-11. doi: 10.1016/j.yrtph.2016.05.005. Epub 2016 May 6.
Aralia elata Seem. (A. elata) is a traditional Chinese medicine to treat some diseases. This investigation aims to evaluate the pharmaceutical safety of the ethanol extract of A. elata leaves, namely ethanol leaves extract (ELE), in Beagle dogs. In sub-chronic oral toxicity study, dogs were treated with the ELE at doses of 50, 100 and 200 mg/kg for 12 weeks and followed by 4 weeks recovery period. During experimental period, clinical signs, mortality, body temperature, food consumption and body weight were recorded. Analysis of electrocardiogram, urinalysis, ophthalmoscopy, hematology, serum biochemistry, organ weights and histopathology were performed. The results showed that both food consumption and body weight significantly decreased in high-dose group. Treatment-related side effects and mortality were observed in high-dose female dogs. Some parameters showed significant alterations in electrocardiogram, urinalysis, serum biochemistry and relative organ weights. These alterations were not related to dose or consistent across gender, which were ascribed to incidental and biological variability. The findings in this study indicated that the no-observed adverse effect level (NOAEL) of the ELE was 100 mg/kg in dogs and provided a vital reference for selecting a safe application dosage for human consumption.
辽东楤木(Aralia elata Seem.,即辽东楤木)是一种用于治疗某些疾病的传统中药。本研究旨在评估辽东楤木叶乙醇提取物,即乙醇叶提取物(ELE)对比格犬的药物安全性。在亚慢性口服毒性研究中,犬分别以50、100和200mg/kg的剂量接受ELE治疗12周,随后有4周的恢复期。在实验期间,记录临床症状、死亡率、体温、食物摄入量和体重。进行了心电图分析、尿液分析、检眼镜检查、血液学检查、血清生化检查、器官重量测量和组织病理学检查。结果表明,高剂量组的食物摄入量和体重均显著下降。在高剂量雌性犬中观察到与治疗相关的副作用和死亡率。心电图、尿液分析、血清生化和相对器官重量的一些参数出现了显著变化。这些变化与剂量无关,也不存在性别一致性,这归因于偶然因素和生物学变异性。本研究结果表明,ELE对犬的无观察到不良反应水平(NOAEL)为100mg/kg,为选择人类食用的安全应用剂量提供了重要参考。